Dr. Spitzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
444 S San Vicente Blvd
Suite 603
Los Angeles, CA 90048Phone+1 310-423-9211Fax+1 310-665-7256- Is this information wrong?
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Orthopaedic Surgery, 1992 - 1993
- University of Pennsylvania Health SystemResidency, Orthopaedic Surgery, 1987 - 1992
- David Geffen School of Medicine at UCLAClass of 1987
Certifications & Licensure
- CA State Medical License 1992 - 2024
- MA State Medical License 1992 - 2011
- PA State Medical License 1990 - 2008
- American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
Publications & Presentations
PubMed
- Intra-Articular Corticosteroid Injections Into a Preexisting Total Knee Arthroplasty are Associated With Increased Risk of Periprosthetic Joint Infection and Revision.Caleb R Durst, Kevin T Rezzadeh, Justin P Than, Sean S Rajaee, Andrew I Spitzer> ;Arthroplasty Today. 2023 Dec 1
- Isolated Liner Exchange Versus All-Component Revision for Instability After Total Knee Arthroplasty.Eytan M Debbi, Caleb R Durst, Kevin T Rezzadeh, Andrew I Spitzer, Sean S Rajaee> ;The Journal of Arthroplasty. 2024 Mar 1
- 1 citationsRevision total knee arthroplasty for arthrofibrosis improves range of motion.Zachary A Rockov, Connor T Byrne, Kevin T Rezzadeh, Caleb R Durst, Andrew I Spitzer, Guy D Paiement, Brad L Penenberg, Sean S Rajaee> ;Knee Surgery, Sports Traumatology, Arthroscopy. 2023 May 1
- Join now to see all
Press Mentions
- Flexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI) World CongressMay 2nd, 2019
- Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTA® (Triamcinolone Acetonide Extended-Release Injectable Suspension) in Rheumatology and TherapyFebruary 11th, 2019
Hospital Affiliations
- Cedars-Sinai Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: